Which of the following features best distinguishes systemic lupus erythematosus (SLE) from systemic sclerosis (SSc) in a 32-year-old Indian woman presenting with polyarthritis and skin involvement?

Explanation

## Distinguishing SLE from Systemic Sclerosis ### Clinical Context Both SLE and SSc are systemic autoimmune disorders with overlapping features (Raynaud's, arthritis, pulmonary involvement), but their pathogenic mechanisms and antibody profiles differ significantly. ### Key Discriminating Features | Feature | SLE | Systemic Sclerosis | |---------|-----|--------------------| | **Malar rash** | Characteristic (50–60%) | Absent or rare | | **Photosensitivity** | Common (40–70%) | Uncommon | | **ANA pattern** | Homogeneous, speckled (95%+) | Centromere, Scl-70 (70–80%) | | **Anti-dsDNA / Anti-Smith** | Highly specific for SLE | Absent | | **Skin involvement** | Non-scarring, malar, discoid | Fibrotic, sclerotic (hands, face) | | **Raynaud's phenomenon** | 15–30% | 90%+ | | **Renal involvement** | Lupus nephritis (30–50%) | Scleroderma renal crisis (rare) | **Key Point:** Malar rash with photosensitivity is a hallmark of SLE and is absent in SSc. When combined with positive ANA (which is present in both), this triad strongly favors SLE. ### Why This Matters **High-Yield:** The malar rash + photosensitivity + ANA positivity is a **pathognomonic cluster for SLE**. It is part of the ACR/EULAR classification criteria and is rarely seen in SSc. **Clinical Pearl:** Raynaud's phenomenon, anti-centromere antibodies, and pulmonary fibrosis are more characteristic of SSc. However, these are NOT unique to SSc—they can occur in SLE overlap syndromes. The malar rash with photosensitivity, by contrast, is almost never seen in pure SSc. ### Antibody Specificity **Mnemonic: SLED** (SLE-defining antibodies) - **S**mith (anti-Sm) — 20–30% of SLE, highly specific - **L**upus anticoagulant — 10–15% of SLE - **E**xtractable nuclear antigen (anti-Ro/SSA, anti-La/SSB) — 40–60% of SLE - **D**ouble-stranded DNA (anti-dsDNA) — 60–70% of SLE, correlates with nephritis In contrast, SSc is characterized by **anti-centromere** (ACA, 20–30%) and **anti-Scl-70** (Topoisomerase I, 30–40%). [cite:Robbins 10e Ch 6]